Rafferty Asset Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.17M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $660K | Sell |
|
|||||
|
2021
Q3 | $806K | Sell |
|
|||||
|
2021
Q2 | $1.24M | Buy |
|
|||||
|
2021
Q1 | $1.26M | Buy |
|
|||||
|
2020
Q4 | $109K | Sell |
|
|||||
|
2020
Q3 | $325K | Buy |
|
|||||
|
2020
Q2 | $185K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $483K | Sell |
|
|||||
|
2019
Q2 | $815K | Sell |
|
|||||
|
2019
Q1 | $973K | Buy |
|